Prenatal exposures to LTP-patterned magnetic fields: quantitative effects on specific limbic structures and acquisition of contextually conditioned fear.

Weak (<1 microT) complex magnetic fields (CMFs) may exert their behavioral influences through the hippocampus by resonating by accident or design with intrinsic electrical patterns. Rats were exposed prenatally to one of four intensities of a CMF (either <5 nanoTesla [nT], 10-50 nT, 50-500 nT, or 500-1000 nT) designed to interact with the process of Long-Term Potentiation (LTP) in the hippocampus. Rats then underwent testing in the forced swim, open field, and fear-conditioning procedures. The cell densities of all amygdaloid nuclei, specific hypothalamic structures, and the major regions of the hippocampus were quantified. Results showed that acquisition of conditioned fear was strongly inhibited in animals exposed to LTP-CMFs. Rats exposed to intensities above 10 nT showed decreased cell density in the CA2 fields of the hippocampus; more neurons were present in the CA1 fields of rats exposed to the 10-50 nT intensities compared to all other groups. A decrease in cell density in the medial preoptic nucleus was linearly dependent on field intensity. In the forced-swim test, swimming was decreased in rats that had been exposed to low (10-50 nT) and medium intensity (50-500 nT) LTP-CMFs in a manner consistent with monoamine modulation. In the open field, exposed rats were indistinguishable from controls. These findings support the hypothesis that continuous exposure during prenatal development to CMFs designed to simulate intrinsic LTP within the hippocampus can affect adult behaviors specific to this structure and produce quantitative alterations in neuronal density.

Developmental effects of perinatal exposure to extremely weak 7 Hz magnetic fields and nitric oxide modulation in the Wistar albino rat.

Prenatal exposure of pregnant dams to oscillating magnetic fields can cause behavioural deficits in their offspring which persist into adulthood. These changes are waveform-specific and may involve nitric oxide. To investigate the interaction between nitric oxide modulation and perinatal magnetic fields, dams were exposed from 2 days before to 14 days after birth to one of six magnetic field conditions (1, 5, 10, 50 or 500 nT or sham) and given either water, 1g/L nitric oxide precursor l-arginine or 0.5 g/L nitric oxide synthase inhibitor n-methylarginine. At weaning (22d), their offspring were placed in the open field for observation. Rats given 50 nT field or 500 nT field+water were hyperactive and showed increased rearing and bodyweight. These strong effects were attenuated or absent in groups given 50 or 500 nT field+n-methylarginine. Groups given sham field+l-arginine were behaviourally similar to animals given 50 or 500 nT field+water. Higher intensity fields showed robust behavioural and physiological effects. In general, these effects were counteracted by co-administration of nitric oxide synthase inhibitor n-methylarginine, which had little effect on its own. Shams given NO precursor l-arginine were highly similar to those given any higher intensity magnetic field. Results support a critical developmental role of NO and the involvement of NO in magnetic field effects.

Emerging synergisms between drugs and physiologically-patterned weak magnetic fields: implications for neuropharmacology and the human population in the twenty-first century.

Synergisms between pharmacological agents and endogenous neurotransmitters are familiar and frequent. The present review describes the experimental evidence for interactions between neuropharmacological compounds and the classes of weak magnetic fields that might be encountered in our daily environments. Whereas drugs mediate their effects through specific spatial (molecular) structures, magnetic fields mediate their effects through specific temporal patterns. Very weak (microT range) physiologically-patterned magnetic fields synergistically interact with drugs to strongly potentiate effects that have classically involved opiate, cholinergic, dopaminergic, serotonergic, and nitric oxide pathways. The combinations of the appropriately patterned magnetic fields and specific drugs can evoke changes that are several times larger than those evoked by the drugs alone. These novel synergisms provide a challenge for a future within an electromagnetic, technological world. They may also reveal fundamental, common physical mechanisms by which magnetic fields and chemical reactions affect the organism from the level of fundamental particles to the entire living system.